1. Examining the Role of Pharmacokinetics in Hemophilia

2. Role of PK Studies in Patients With Hemophilia

3. The Science of Pharmacokinetics

4. Pharmacokinetics

5. Pharmacokinetic Definitions

6. Hemophilia Overview

7. Intermittent Infusions (Bolus)

8. Continuous Infusions

9. Half-Life Differences With Types of Factor VIII Deficiency Treatments

10. Available Extended Half-Life Products for Factor VIII

11. Half-Life Differences With Types of Factor IX Deficiency Treatments

12. Available Extended Half-Life Products for Factor IX

13. Assays for Hemophilia

14. Factor Dosing General Overview

15. Clinical Implications of PK Studies in Hemophilia Management

16. Clinical Implications of PK Studies in Hemophilia Treatment

17. PK Studies Optimize Treatment

18. Personalized Prophylaxis

19. Challenges of PK Studies

20. Practical Approaches to PK Studies Peak/Trough Levels

21. Practical Approaches to PK Studies Population PK Studies

22. Planning Regimen With Patient/Family Factors to Consider

23. Patient/Family Education

24. Patient/Family Education and Participation

25. Practical Implementation

26. Role of Nurses and Pharmacists in PK Assessment

27. Comprehensive Hemophilia Care Team

28. Role of the HTC Team Pharmacist

29. Role of the HTC Team Nursing

30. Role of HTC Team (cont)

31. Closing the Loop

32. Abbreviations